EG Labo selects OpenPharma

EG Labo has been present on the generic drug market since 1996. In January 2020, the pharmaceutical company equips all field forces with the OpenPharma solution to gain efficiencies: Increased visibility and responsiveness in customer engagement (integration of wholesale data on one hand, and claim management on the other), optimization of commercial activity (dynamic qualification) and digital transformation through electronic document management (digital contracts).